Percutaneous and surgical management of aortic stenosis in the SWEDEHEART registry (2013-2023): a nationwide observational study.

ABSTRACT:

Background

Management of severe aortic stenosis (AS) has evolved over the past decade, driven by the widespread adoption of transcatheter aortic valve implantation (TAVI). This study aims to assess trends in procedural volumes, patient characteristics, and outcomes for patients undergoing TAVI or surgical aortic valve replacement (SAVR) in Sweden.

Methods

This was a descriptive, non-comparative, nationwide cohort study using the SWEDEHEART registry. We included 21,383 patients who underwent TAVI or SAVR between 2013 and 2023 (11,366 TAVI and 10,017 SAVR). Trends in patient characteristics, preoperative risk, complications and mortality were examined.

Findings

TAVI procedures increased from 307 (26.1%, n = 307/1174) in 2013 to 1851 (71.2%, n = 1851/2601) in 2023, while

SUBMITTER: Todt J 

PROVIDER: S-EPMC12630323 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature